Since its first documentation, breast cancer (BC) has been a conundrum that ails millions of
women every year. This cancer has been well studied by researchers all over the world …

Despite advances in breast cancer diagnosis and treatment, many patients still fail therapy,
resulting in disease progression, recurrence, and reduced overall survival. Historically …

Breast cancer is the most frequent type of malignancy in women worldwide, and drug
resistance to the available systemic therapies remains a major challenge. At the molecular …

Abstract Development of therapeutic resistance and metastasis is a major challenge with
current breast cancer (BC) therapy. Mounting evidence suggests that a subpopulation of …

Breast cancer stem cells (BCSCs) play a vital role in tumor progression and metastasis.
They are heterogeneous and inherently radio-and chemoresistant. They have the ability to …

Drug resistance is a major challenge in breast cancer (BC) treatment at present.
Accumulating studies indicate that breast cancer stem cells (BCSCs) are responsible for the …

Breast cancer is the most frequent cancer among women worldwide. Therapeutic strategies
to prevent or treat metastatic disease are still inadequate although great progress has been …

Breast cancer (BCa) is one of the most prevalent malignant tumors affecting women's health
worldwide. The recurrence and metastasis of BCa have made it a long-standing challenge …

Breast cancer is the most common type of cancer found in women and today represents a
significant challenge to public health. With the latest breakthroughs in molecular biology and …

Breast cancer stem cells (CSC) have been postulated recently as responsible for failure of
breast cancer treatment. The purpose of this study is to review breast CSCs molecular …